Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Press release
| Date: | 15 March 2010 |
|---|---|
| Time: | 11:15 |
| Contact: | Press Office 020 3080 7651
or press.office@mhra.gsi.gov.uk Out-of-hours 07770 446 189 |
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Appointments Commission are pleased to announce the reappointment of one member to the Herbal Medicines Advisory Committee (HMAC).
The HMAC is an independent body that works closely with the MHRA, advising UK health ministers on traditional herbal medicines.
Dr Jidong Wu is a traditional Chinese medicine practitioner and a senior lecturer in traditional Chinese medicine at Middlesex University. Dr Wu is also a member of the Chinese Association of Acupuncture and Moxibustion in China, fellow member of the Association of Traditional Chinese Medicine and honour member of the Register of Chinese Herbal Medicine.
Dr Wu has been re-appointed to the HMAC for a four year term commencing 1 April 2010.
These appointments are not remunerated, however a fee of £275 per meeting for members is paid to cover preparation and attendance together with any travel and accommodation costs.
All appointments are made on merit. Political activity plays no part in the selection process. In accordance with the original Nolan Recommendations there is a requirement for appointees’ political activity (if declared) to be made public.
The appointments have been made in accordance with the Commissioner for Public Appointments Code of Practice.
Notes to Editor
1. Details of the Herbal Medicines Advisory Committee can be found on the MHRA website.
2. Details of the Appointments Commission is available the Appointments Commission website (external link).
3. Details of the Nolan Recommendations can be found on the Commissioner for Public Appointments website (external link).
4. The MHRA is the government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe. No product is risk-free. Underpinning all our work lie robust and fact-based judgments to ensure that the benefits to patients and the public justify the risks. We keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem. We encourage everyone –the public and healthcare professionals as well as the industry – to tell us about any problems with a medicine or medical device, so that we can investigate and take any necessary action.
Press release: Appointment to the Herbal Medicines Advisory Committee 
